Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers. | Int J Mol Sci | 2020 | 33198323 | PubTator, text mining | PubMed |
| Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38. | Nat Commun | 2020 | 33188182 | PubTator, text mining | PubMed |
| Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 Inhibition. | Int J Mol Sci | 2020 | 33172202 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| Epigenome-wide association study for pesticide (Permethrin and DEET) induced DNA methylation epimutation biomarkers for specific transgenerational disease. | Environ Health | 2020 | 33148267 | PubTator, text mining | PubMed |
| PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptor, directly inhibits p38 MAPK. | Biochem Pharmacol | 2020 | 33132165 | PubTator, text mining | PubMed |
| The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression. | Int J Mol Sci | 2020 | 33126568 | PubTator, text mining | PubMed |
| An Integrative Serum Pharmacology-Based Approach to Study the Anti-Tumor Activity of B. paniculatum Aqueous Bulb Extract on the Human Hepatocellular Carcinoma Cell Line BEL-7404. | Front Pharmacol | 2020 | 33123002 | PubTator, text mining | PubMed |
| Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins. | Front Cell Dev Biol | 2020 | 33117795 | PubTator, text mining | PubMed |
| Comprehensive Biological Evaluation of Biomaterials Used in Spinal and Orthopedic Surgery. | Materials (Basel) | 2020 | 33114571 | PubTator, text mining | PubMed |
| Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction. | EBioMedicine | 2020 | 33096483 | PubTator, text mining | PubMed |
| Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. | Signal Transduct Target Ther | 2020 | 33093441 | PubTator, text mining | PubMed |
| Allosteric inhibition of LRRK2, where are we now. | Biochem Soc Trans | 2020 | 33079169 | PubTator, text mining | PubMed |
| Identifying the Transcriptional Response of Cancer and Inflammation-Related Genes in Lung Cells in Relation to Ambient Air Chemical Mixtures in Houston, Texas. | Environ Sci Technol | 2020 | 33064461 | PubTator, text mining | PubMed |
| p38β and Cancer: The Beginning of the Road. | Int J Mol Sci | 2020 | 33053909 | PubTator, text mining | PubMed |
| Aggregation and disaggregation features of the human proteome. | Mol Syst Biol | 2020 | 33022891 | PubTator, text mining | PubMed |
| Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture. | Int J Mol Sci | 2020 | 33019495 | PubTator, text mining | PubMed |
| Potential Role of Gene Regulator NFAT5 in the Pathogenesis of Diabetes Mellitus. | J Diabetes Res | 2020 | 33015193 | PubTator, text mining | PubMed |
| Functions of p38 MAP Kinases in the Central Nervous System. | Front Mol Neurosci | 2020 | 33013322 | PubTator, text mining | PubMed |
| Oxygen glucose deprivation/re-oxygenation-induced neuronal cell death is associated with Lnc-D63785 m6A methylation and miR-422a accumulation. | Cell Death Dis | 2020 | 32999283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=33